Factors Affecting Serum Paraoxonase 1 Activity in Migrant and Resident Gujarati South Asians
暂无分享,去创建一个
D. Prabhakaran | K. Reddy | K. Cruickshank | Jeetesh V. Patel | P. Durrington | D. Bhatnagar | M. Mackness | B. Mackness | A. Vyas | E. Hughes | R. Mirrielees
[1] S. Humphries,et al. Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study , 2012, Disease markers.
[2] A. Koc,et al. Paraoxonase and Arylesterase Activities in Children With Iron Deficiency Anemia and Vitamin B12 Deficiency Anemia , 2012, Pediatric hematology and oncology.
[3] K. Gill,et al. Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics. , 2012, Gene.
[4] G. Rimbach,et al. Determinants of paraoxonase 1 status: genes, drugs and nutrition. , 2011, Current medicinal chemistry.
[5] Ferdinando Giacco,et al. Oxidative stress and diabetic complications. , 2010, Circulation research.
[6] J. Joven,et al. Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated role , 2010, Journal of Molecular Histology.
[7] J. Joven,et al. Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results , 2010, Clinical chemistry and laboratory medicine.
[8] Hieronim Jakubowski,et al. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. , 2010, Advances in experimental medicine and biology.
[9] M. Sandhu,et al. Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study , 2009, PloS one.
[10] Y. Ikeda,et al. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes , 2009, Acta Diabetologica.
[11] Y. Ikeda,et al. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes. , 2008, Metabolism: clinical and experimental.
[12] D. Shih,et al. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? , 2008, Current opinion in lipidology.
[13] T. Hayek,et al. Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. , 2008, Free radical biology & medicine.
[14] D. Arveiler,et al. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study. , 2008, Atherosclerosis.
[15] E. Topol,et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. , 2008, JAMA.
[16] D. Shih,et al. Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[17] M. Mackness,et al. Defective Metabolism of Oxidized Phospholipid by HDL From People With Type 2 Diabetes , 2006, Diabetes.
[18] D. Prabhakaran,et al. Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. , 2006, Atherosclerosis.
[19] D. Shih,et al. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. , 2005, Atherosclerosis.
[20] P. McElduff,et al. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy , 2004, Clinical endocrinology.
[21] P. McElduff,et al. Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study , 2003, Circulation.
[22] P. Durrington,et al. The paraoxonase gene family and coronary heart disease , 2002, Current opinion in lipidology.
[23] BjörnFagerberg,et al. Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) , 2002 .
[24] O. Kordonouri,et al. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. , 2001, Metabolism: clinical and experimental.
[25] J. Ferrières,et al. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease , 2000, European journal of clinical investigation.
[26] B. La Du,et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. , 1999, Free radical biology & medicine.
[27] B. La Du,et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.
[28] P. Zimmet,et al. Non‐insulin‐dependent Diabetes and 11‐Year Mortality in Asian Indian and Melanesian Fijians , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[29] A. Boulton,et al. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[30] R. Balarajan. Ethnicity and variations in the nation's health. , 1995, Health trends.
[31] S. Adkins,et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.
[32] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.
[33] A. Motulsky,et al. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. , 1988, American journal of human genetics.
[34] G. Siest,et al. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. , 1986, Annales de biologie clinique.
[35] R. Krauss,et al. Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.
[36] L. Bn,et al. The polymorphic paraoxonase/arylesterase isozymes of human serum. , 1984 .
[37] B. La Du,et al. The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.
[38] D. Beevers,et al. Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England. , 1980, British medical journal.